merged_ozempic-alzheimers.txt
<question_number>1</question_number>
<answer>N/A</answer>

<question_number>2</question_number>
<answer>N/A</answer>

<question_number>3</question_number>
<answer>N/A</answer>

<question_number>4</question_number>
<answer>N/A</answer>

<question_number>5</question_number>
<answer>N/A</answer>

<question_number>6</question_number>
<answer>N/A</answer>

<question_number>7</question_number>
<answer>N/A</answer>

<question_number>8</question_number>
<answer>N/A</answer>

<question_number>9</question_number>
<answer>N/A</answer>

<question_number>10</question_number>
<answer>N/A</answer>

<question_number>11</question_number>
<answer>liraglutide</answer>
<other>The article states: "Preliminary findings from one study of about 200 patients were presented at an Alzheimer's Association meeting last summer. They showed that patients with mild Alzheimer's disease who received an older, similar medication (liraglutide, sold under the brand name Victoza), had slower declines in both their cognition and brain volume compared with patients who received a placebo."</other>

<question_number>12</question_number>
<answer>about 10 percent</answer>
<other>The article states: "A paper published this month reviewing a Veterans Affairs database similarly found that people prescribed these drugs were less likely to develop dementia compared with those who took other diabetes drugs. The benefit was more modest, though, with a roughly 10 percent decreased risk."</other>

<question_number>13</question_number>
<answer>insulin resistance</answer>
<other>The article states: "The medications can also curb insulin resistance, a hallmark of diabetes. Healthy insulin functioning is important for memory formation, and insulin resistance has been linked to Alzheimer's disease. Research in animals suggests that because these drugs may improve insulin signaling in the brain, they could protect against neurodegeneration"</other>

<question_number>14</question_number>
<answer>N/A</answer>
<other>The article only mentions tau protein, not any other protein accumulation that was targeted by failed drugs.</other>

<question_number>15</question_number>
<answer>N/A</answer>

<question_number>16</question_number>
<answer>exenatide</answer>
<other>The article states: "Research has found that an older and less common drug, exenatide (sold under the brand name Byetta), can access deeper parts of the brain, Dr. Skibicka said. That includes the hippocampus, an area that is damaged early on in Alzheimer's disease. The data for other medications, including semaglutide and liraglutide, are more mixed."</other>

<question_number>17</question_number>
<answer>N/A</answer>

<question_number>18</question_number>
<answer>N/A</answer>
<other>While Dr. Edison is quoted saying "The drug is not only working on the insulin resistance...It's clearly working on the other mechanisms," he doesn't specify a primary mechanism.</other>

<question_number>19</question_number>
<answer>tirzepatide</answer>
<other>The article mentions in the "What to Know" section: "Shortage Ends: The F.D.A. declared an end to the two-year shortage of tirzepatide, the substance in Zepbound and Mounjaro. The change will expand access to the drugs."</other>

<question_number>20</question_number>
<answer>hippocampus</answer>
<other>The article states: "Research has found that an older and less common drug, exenatide (sold under the brand name Byetta), can access deeper parts of the brain, Dr. Skibicka said. That includes the hippocampus, an area that is damaged early on in Alzheimer's disease."</other>